ABT - Reckitt Benckiser: Maybe Caution Is Appropriate
2024-03-26 13:21:52 ET
Summary
- Reckitt Benckiser reported mediocre full-year results for fiscal 2023 as well as a mediocre guidance for fiscal 2024.
- Aside from the results, Mead Johnson - a subsidiary - had to pay a $60 million dollar fine and investors obviously fear more lawsuits to come.
- The stock is probably undervalued but at this point, we should be rather cautious about an investment.
In November 2023 I wrote my last article about Reckitt Benckiser ( RBGPF ) and I stated my optimism for the long run. And while we can certainly argue that four to five months is not really “the long run”, the stock performed horrible since my last article....
Reckitt Benckiser: Maybe Caution Is Appropriate